SNCA and Parkinson disease: Nevertheless, the trend from the majority of the results is in line with findings in animal models for PD, in which α-synuclein A53T overexpression leads to deceased serum TAG levels [239], and 6-OHDA treatment decreases TAG levels in retroperitoneal white adipose tissue [240].